Page 153 - CW E-Magazine (21-11-2023)

Pharmaceuticals

CPHI INDIA

‘India pharma executives bullish on growth prospects

in 2024’

Ahead of this month’s pharma in the New Delhi Capital Region with Pre-Connect Congress’, the ‘Women
trade exhibition, CPHI & PMEC India more than 1,800 exhibitors and is in Pharma Roundtable’ and the ‘Indian
(28th- 30th November, 2023), the event expected to draw over 48,000 execu- Pharma Awards’.
organiser Informa Markets has con- tives from 120 countries.
fi rmed that India has highest confi dence The Awards, now in its 10th edi-
in outsourcing growth globally among Ms. Olga Ponomareva-Stepnaya, tion, will honour excellence across 13
its pharma professionals. Brand Manager, CPHI India commen- categories, highlighting the invalua-
ted, “India is in a very strong moment ble work of industry champions, stal-
Building on the back of the recently with its pharma industry boosted by a warts & visionaries from across the
released CPHI Annual Report, in which number of tailwinds that our analysts Indian pharma industry. The awards
India was widely seen as a global win- believe will see it outperform most night will be held in the evening of
ner, executives from India have offered other regions. What we also see is that 28th November 2023 at the Expo
up the most positive outlook for 2024 – supply chains within India are evolving Centre. In line with wider pharma
with 61% ‘highly positive’ and a and growing alongside this to support trends across the country for a more
further 37% ‘moderately confi dent’. the industry, which is why CPHI India sustainable industry, this year’s edition
This result contrasts with a global is critical to maintaining the country’s will be the most sustainable to date
average of just 37% ‘highly positive’ and wider region’s moment into 2024.” and is powered exclusively by renew-
and 54% ‘moderate’ in all executives. able energy sources. Registration to
The event will feature the ‘India the event is free until November 24th,
CPHI & PMEC India will be held at Pharma Week’ encompassing the an- 2023 and the pass provides access to
the India Expo Centre (Greater Noida) nual ‘CEO Roundtable’, the ‘Pharma both the online and in person platforms.
INVESTMENT PLANS

Olon to expand Mahad site’s production capacity by 45%

Italian API producer, Olon S.p.A., The new expansion plan is also stra-
has announced a multi-year expansion tegic for increasing the group’s overall
plan for its production site in Mahad production volumes, supporting its ex-
(Maharashtra). The company plans to pected growth in the coming years, as
invest around €10-mn to increase pro- part of the intermediate products will
duction capacity of both intermediates be used at other sites in the network.
and fi nished APIs at the site by “several The investment is part of a strategy of
dozen tonnes per year”. The expansion, continuous strengthening of techno-
which confi rms the strategic role of the logical and production capabilities,
Indian site within the Italian group’s based on which Olon has only recently
integrated production network, will gradual further capacity growth until installed at the Mahad site a new
increase the plant’s total production 2026. The Olon site in Mahad, fully high-containment production line and
capacity by 45% in chemical synthesis, integrated into the platform of 11 plants a major upgrade of fermentation capacity,
particularly for products in high worldwide with production of more as well as new systems for generating
demand in the global supply chain. than 20 APIs and intermediates for the renewable energy.
rest of the group by synthetic route, has
The new production line will include developed a particular leadership posi- Olon had, in 2018, acquired the
reactors and fi lter dryers equipped with tion in the fermentation production of Mahad site, which supplied ingredients
all necessary utilities, and will come the rife family (rifampicin, rifaximin) to Sandoz, a division of the Novartis
into operation in Q2 2024, allowing for and its intermediates (Rifa S, Rifa O). Group.

Chemical Weekly November 21, 2023 153

Contents Index to Advertisers Index to Products Advertised